Gaining ground on breast cancer.
Esteva
Francisco J
FJ
University of Texas M.D. Anderson Cancer Center, TX, USA.
Hortobagyi
Gabriel N
GN
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D003131:Combined Modality Therapy; D016503:Drug Delivery Systems; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors; D015996:Survival Rate
D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases